ATE132900T1 - Gene, die ein protein mit menschlicher macif- aktivität kodieren, expressionsvektoren mit diesen genen, transformantenzellen und proteine mit menschlicher macif-aktivität - Google Patents

Gene, die ein protein mit menschlicher macif- aktivität kodieren, expressionsvektoren mit diesen genen, transformantenzellen und proteine mit menschlicher macif-aktivität

Info

Publication number
ATE132900T1
ATE132900T1 AT90304203T AT90304203T ATE132900T1 AT E132900 T1 ATE132900 T1 AT E132900T1 AT 90304203 T AT90304203 T AT 90304203T AT 90304203 T AT90304203 T AT 90304203T AT E132900 T1 ATE132900 T1 AT E132900T1
Authority
AT
Austria
Prior art keywords
genes
human macif
macif activity
protein
activity
Prior art date
Application number
AT90304203T
Other languages
English (en)
Inventor
Motowo Tomita
Yuji Sugita
Toshiyuki Takemoto
Kiyoshi Furuichi
Makoto Takayama
Ko Yusakawa
Shinya Yano
Noboru Yamaji
Katsuhisa Ito
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of ATE132900T1 publication Critical patent/ATE132900T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT90304203T 1989-04-21 1990-04-19 Gene, die ein protein mit menschlicher macif- aktivität kodieren, expressionsvektoren mit diesen genen, transformantenzellen und proteine mit menschlicher macif-aktivität ATE132900T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP10308889 1989-04-21
JP17993389 1989-07-12
JP23098389 1989-09-06
JP23824689 1989-09-13
JP24781889 1989-09-21
JP28119789 1989-10-27

Publications (1)

Publication Number Publication Date
ATE132900T1 true ATE132900T1 (de) 1996-01-15

Family

ID=27552152

Family Applications (2)

Application Number Title Priority Date Filing Date
AT90304203T ATE132900T1 (de) 1989-04-21 1990-04-19 Gene, die ein protein mit menschlicher macif- aktivität kodieren, expressionsvektoren mit diesen genen, transformantenzellen und proteine mit menschlicher macif-aktivität
AT95200379T ATE202570T1 (de) 1989-04-21 1990-04-19 Gene, die für macif proteine kodieren, expressionsvektoren mit diesem genen, und transformantenzellen mit diesem proteinen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT95200379T ATE202570T1 (de) 1989-04-21 1990-04-19 Gene, die für macif proteine kodieren, expressionsvektoren mit diesem genen, und transformantenzellen mit diesem proteinen

Country Status (12)

Country Link
US (1) US5532339A (de)
EP (2) EP0672683B1 (de)
JP (1) JP2828148B2 (de)
KR (1) KR0150000B1 (de)
AT (2) ATE132900T1 (de)
AU (1) AU640643B2 (de)
CA (1) CA2014948C (de)
DE (2) DE69024693T2 (de)
DK (1) DK0394035T3 (de)
ES (1) ES2084658T3 (de)
GR (1) GR3019347T3 (de)
IE (2) IE74168B1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795736A (en) * 1989-04-21 1998-08-18 Yamanouchi Pharmaceutical Co., Ltd. Genes coding for a protein having human MACIF activity, expression vectors containing said genes, transformant cells and proteins having human macif activity
US5573940A (en) * 1989-06-12 1996-11-12 Oklahoma Medical Research Foundation Cells expressing high levels of CD59
AU6015696A (en) * 1995-06-16 1997-01-15 Yamanouchi Pharmaceutical Co., Ltd. Modified polypeptide, dna encoding the same, transformant, and medicinal composition containing the polypeptide
US7166568B1 (en) 1998-02-09 2007-01-23 Oklahoma Medical Research Foundation Compositions and methods to inhibit formation of the C5b-9 complex of complement
WO2001010908A1 (en) * 1999-08-04 2001-02-15 Amgen Inc. Ntr3, a member of the tnf-receptor supergene family
US6835545B2 (en) 2000-05-08 2004-12-28 President And Fellows Of Harvard College Methods, products and treatments for diabetes
US7439330B2 (en) 2000-05-08 2008-10-21 President And Fellows Of Harvard College Anti-glycated CD59 antibodies and uses thereof
CN1325889A (zh) * 2000-05-26 2001-12-12 上海博德基因开发有限公司 一种新的多肽——人Kazal型抑制因子11和编码这种多肽的多核苷酸
US7833725B2 (en) 2005-01-06 2010-11-16 President And Fellows Of Harvard College Mass spectrometric methods and products
AU2015202046B2 (en) * 2008-02-15 2017-06-29 Tufts University A humanized model of membrane attack complex (mac) formation on murine retina and compositions, kits and methods for treatment of macular degeneration
CA2843684A1 (en) * 2010-08-13 2012-02-16 Tufts University Compositions, kits and methods for treatment of macular degeneration using soluble membrane-independent cd59 protein
US9068006B2 (en) 2010-08-25 2015-06-30 President And Fellows Of Harvard College Glycated CD59 peptides, their preparation, and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109113A (en) * 1986-05-02 1992-04-28 Genentech, Inc. Membrane anchor fusion polypeptides
US5179198A (en) * 1988-07-11 1993-01-12 Hidechika Okada Glycoprotein and gene coding therefor
US4935494A (en) * 1988-11-15 1990-06-19 City Of Hope C-terminal peptide and protein sequencing

Also Published As

Publication number Publication date
ATE202570T1 (de) 2001-07-15
JP2828148B2 (ja) 1998-11-25
EP0672683A1 (de) 1995-09-20
KR0150000B1 (ko) 1998-08-17
EP0394035A2 (de) 1990-10-24
EP0672683B1 (de) 2001-06-27
CA2014948C (en) 2000-12-12
IE960874L (en) 1990-10-21
DE69024693T2 (de) 1996-07-11
JPH03201985A (ja) 1991-09-03
KR900016465A (ko) 1990-11-13
DE69033756D1 (de) 2001-08-02
IE901426L (en) 1990-10-21
AU640643B2 (en) 1993-09-02
GR3019347T3 (en) 1996-06-30
DK0394035T3 (da) 1996-05-13
DE69033756T2 (de) 2002-04-18
DE69024693D1 (de) 1996-02-22
ES2084658T3 (es) 1996-05-16
US5532339A (en) 1996-07-02
EP0394035A3 (de) 1991-08-21
EP0394035B1 (de) 1996-01-10
CA2014948A1 (en) 1990-10-21
IE74168B1 (en) 1997-07-02
AU5372690A (en) 1990-11-08

Similar Documents

Publication Publication Date Title
ZA91134B (en) New proteins produced by human lymphocytes,dna sequence encoding these proteins and their pharmaceutical and biological uses
NO158950C (no) Dna-sekvens som koder for et polypeptid med human fibroblast-interferonaktivitet, fremgangsmaate for dens fremstilling, samt fremgangsmaate for fremstilling av et plasmid.
ES8306324A1 (es) "proceso para la produccion microbiana de interferon fibroblasto humano".
ATE318912T1 (de) Polynukleotid kodierend für ein polypeptid mit heparanase-aktivität und dessen expression in transduzierten zellen
IL118201A0 (en) Erythropoietin free of animal proteins processes for production and use thereof
HUT69615A (en) Protein c d
ATE232237T1 (de) Herstellung von funktionellen, menschlichen urokinaseproteinen
SE8106641L (sv) Hybrida humanleukocytinterferoner
DE3882593D1 (de) Polypeptid und dessen herstellung.
NO910982D0 (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
ATE132900T1 (de) Gene, die ein protein mit menschlicher macif- aktivität kodieren, expressionsvektoren mit diesen genen, transformantenzellen und proteine mit menschlicher macif-aktivität
AU637139B2 (en) Gm-csf protein, its derivatives, the preparation of proteins of this type, and their use
FI90667C (fi) Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
DK0433117T3 (da) Nye polypeptider, DNA-sekvenser, som muliggør ekspression deraf, samt fremstilling og anvendelse deraf.
BR0000698A (pt) 15, 15'-dioxigenases de beta, beta-caroteno
DE3886517D1 (de) Menschlicher Prourokinase ähnliches Polypeptid.
PT676413E (pt) Proteina de ligacao a interferoes alfa/beta, sua preparacao e utilizacao
FI891308A7 (fi) Uudet polypeptidit, joilla on kasvutekijäaktiivisuutta sekä polypeptideitä koodittavat nukleiinihapposekvenssit
DE3878988D1 (de) 1,2-di(4-isobutylphenyl)aethylen, dessen herstellung und verwendung als zwischenprodukt.
DE68924022D1 (de) Protein mit hemmender Aktivität gegenüber menschlichem Plasmin.
DE68922546D1 (de) Gen-Regulationskassetten, Expressionsvektoren, die diese enthalten und Mikroorganismen, die mit diesen transformiert sind.
ATE92110T1 (de) Menschliches interleukin-4, expressionsvektoren dafuer und diese enthaltende transformanten.
ATE92106T1 (de) Polypeptid und dessen herstellung.
MX9708877A (es) P62, sus variantes, las secuencias de acidos nucleicos que los codifican, y su utilizacion en terapia genica anti-cancerosa.
ATE98990T1 (de) Menschlicher prourokinase aehnliches polypeptid.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee